drugset / Trial / NCT00511914
Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
NaSingle-groupOpen-labelPrevention
Summary
Annual trial for registration of sub-unit influenza vaccine produced in mammalian cell culture, using the strain composition 2007/2008, when administered to adult and elderly subjects
Timeline
- Start
- 2007-07
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cTIV | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.